bioRxiv preprint doi: https://doi.org/10.1101/2020.09.02.280537; this version posted September 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Identification of a novel cobamide remodeling enzyme in the beneficial human gut bacterium 2 Akkermansia muciniphila 3 4 Kenny C. Moka, Olga M. Sokolovskayaa, Alexa M. Nicolasa, Zachary F. Hallberga, Adam 5 Deutschbauerb, Hans K. Carlsonb, and Michiko E. Tagaa# 6 7 aDepartment of Plant & Microbial Biology, University of California, Berkeley, Berkeley, CA 8 9 bEnvironmental Genomics and Systems Biology Division, Lawrence Berkeley National 10 Laboratory, Berkeley, CA 11 12 #Correspondence to
[email protected] 13 14 Running title: Cobamide remodeling in a beneficial gut bacterium 15 16 Abstract word count: 233 17 18 Text word count: 6,114 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.02.280537; this version posted September 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 19 Abstract 20 21 The beneficial human gut bacterium Akkermansia muciniphila provides metabolites to other 22 members of the gut microbiota by breaking down host mucin, but most of its other metabolic 23 functions have not been investigated. A. muciniphila is known to use cobamides, the vitamin B12 24 family of cofactors with structural diversity in the lower ligand, though the specific cobamides it 25 can use have not been examined.